Esperion to Participate in the 2022 Jefferies Global Healthcare Conference

ANN ARBOR, Mich., June 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming 2022 Jefferies Global Healthcare Conference on June 8^th, 2022.

A live audio webcast can be accessed on the investor and media section of the Esperion website at https://www.esperion.com/investor-relations/events. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days.

Esperion Therapeutics

Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. Esperion is the leader in the development of convenient oral, once-daily non-statin LDL-cholesterol lowering drugs for patients with high levels of bad cholesterol. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:
Corporate Communications
[email protected]

You May Also Be Interested In

• Hawk Law Group’s Hawk Helps Hosts Third Annual Bookbag Bash, Providing Back-to-School Supplies to More Than 500 Augusta-Area Students
• BNB Price Prediction 2026 Points to $770 But Whales Chasing Bigger Returns Are Filling Pepeto Before Listing
• StackQuarry Opens Software Research Library Focused On the Costs That Appear After Purchase